Cargando…

Assessment of enhanced influenza vaccination finds that FluAd conveys an advantage in mice and older adults

OBJECTIVES: Enhanced inactivated influenza vaccines (eIIV) aim to increase immunogenicity and protection compared with the widely used standard IIV (S‐IIV). METHODS: We tested four vaccines in parallel, FluZone high dose, FluBlok and FluAd versus S‐IIV in a randomised controlled trial of older adult...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kavian, Niloufar, Hachim, Asmaa, Li, Athena PY, Cohen, Carolyn A, Chin, Alex WH, Poon, Leo LM, Fang, Vicky J, Leung, Nancy HL, Cowling, Benjamin J, Valkenburg, Sophie A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6997034/ https://www.ncbi.nlm.nih.gov/pubmed/32025302 http://dx.doi.org/10.1002/cti2.1107

Ejemplares similares

Vaccination with ADCC activating HA peptide epitopes provides 1 partial protection from influenza infection
por: Kavian, Niloufar, et al.
Publicado: (2020)

Repeated influenza vaccination provides cumulative protection from distinct H3N2 viruses
por: Kavian, Niloufar, et al.
Publicado: (2021)

Antibody landscapes of SARS-CoV-2 can reveal novel vaccine and diagnostic targets
por: Hachim, Asmaa, et al.
Publicado: (2021)

SARS-CoV-2 specific T cell responses are lower in children and increase with age and time after infection
por: Cohen, Carolyn A, et al.
Publicado: (2021)

Cross‐reactive antibody‐dependent cellular cytotoxicity antibodies are increased by recent infection in a household study of influenza transmission
por: Valkenburg, Sophie A, et al.
Publicado: (2019)

Fluad®-MF59®-Adjuvanted Influenza Vaccine in Older Adults
por: Tsai, Theodore F
Publicado: (2013)

The SARS-CoV-2 antibody landscape is lower in magnitude for structural proteins, diversified for accessory proteins and stable long-term in children
por: Hachim, Asmaa, et al.
Publicado: (2021)

SARS-CoV-2 specific T cell responses are lower in children and increase with age and time after infection
por: Cohen, Carolyn A., et al.
Publicado: (2021)

Author Correction: ORF8 and ORF3b antibodies are accurate serological markers of early and late SARS-CoV-2 infection
por: Hachim, Asmaa, et al.
Publicado: (2020)

Effectiveness of adjuvanted seasonal influenza vaccines (Inflexal V(®) and Fluad(®)) in preventing hospitalization for influenza and pneumonia in the elderly: A matched case-control study
por: Gasparini, Roberto, et al.
Publicado: (2013)

Vitamin B(12) conveys a protective advantage to phycosphere-associated bacteria at high temperatures
por: Mars Brisbin, Margaret, et al.
Publicado: (2023)

FluShuffle and FluResort: new algorithms to identify reassorted strains of the influenza virus by mass spectrometry
por: Lun, Aaron TL, et al.
Publicado: (2012)

Phase 4, Post-Marketing Safety Surveillance of the MF59-Adjuvanted Influenza Vaccines FLUAD(®) and VANTAFLU(®) in South Korean Subjects Aged ≥65 Years
por: Yoo, Byung Wook, et al.
Publicado: (2018)

SARS-CoV-2 accessory proteins reveal distinct serological signatures in children
por: Hachim, Asmaa, et al.
Publicado: (2022)

Characterization of SARS-CoV-2 N protein reveals multiple functional consequences of the C-terminal domain
por: Wu, Chao, et al.
Publicado: (2020)

Domain-specific biochemical and serological characterization of SARS-CoV-2 nucleocapsid protein
por: Wu, Chao, et al.
Publicado: (2021)

Characterization of SARS-CoV-2 nucleocapsid protein reveals multiple functional consequences of the C-terminal domain
por: Wu, Chao, et al.
Publicado: (2021)

The Hurdles From Bench to Bedside in the Realization and Implementation of a Universal Influenza Vaccine
por: Valkenburg, Sophie A., et al.
Publicado: (2018)

Postmortem Stability of SARS-CoV-2 in Mouse Lung Tissue
por: Valkenburg, Sophie A., et al.
Publicado: (2021)

The Conveyance of Infection
Publicado: (1897)

Changing role of EMS –analyses of non-conveyed and conveyed patients in Finland
por: Paulin, Jani, et al.
Publicado: (2020)

Universally Immune: How Infection Permissive Next Generation Influenza Vaccines May Affect Population Immunity and Viral Spread
por: Bull, Maireid B., et al.
Publicado: (2021)

T Cells Targeting SARS-CoV-2: By Infection, Vaccination, and Against Future Variants
por: Nguyen, Thi H. O., et al.
Publicado: (2021)

Kmt2c mutations enhance HSC self-renewal capacity and convey a selective advantage after chemotherapy
por: Chen, Ran, et al.
Publicado: (2021)

Pneumatic conveying of solids /
Publicado: (1997)

Conveyance of Contagion by Flies
Publicado: (1875)

Hospital Ambulance Conveyance
Publicado: (1882)

Conveyance of Sound by the Teeth
Publicado: (1864)

Conveyance and Transportation Issues
Publicado: (2009)

Tuberculosis Conveyed by Milk
por: O’Neill, J. M.
Publicado: (1897)

Syphilis Conveyed by Vaccination
Publicado: (1864)

A retrospective comparison between non-conveyed and conveyed patients in ambulance care
por: Vloet, Lilian C. M., et al.
Publicado: (2018)

Advantage of meditation over exercise in reducing cold and flu illness is related to improved function and quality of life
por: Obasi, Chidi N., et al.
Publicado: (2012)

Serologic Responses in Healthy Adult with SARS-CoV-2 Reinfection, Hong Kong, August 2020
por: Chan, Paul K.S., et al.
Publicado: (2020)

Bird flu: lessons from SARS
por: Wong, Gary W.K., et al.
Publicado: (2007)

Pneumatic conveying design guide
por: Mills, David
Publicado: (2016)

Conveying Movement in Music and Prosody
por: Hedger, Stephen C., et al.
Publicado: (2013)

Milk as a Conveyer of Disease
por: Cooper, T. J.
Publicado: (1902)

From SARS and avian flu to swine flu
por: Wong, G.W.K.
Publicado: (2010)

MF59-adjuvanted influenza vaccine (FLUAD®) elicits higher immune responses than a non-adjuvanted influenza vaccine (Fluzone®): A randomized, multicenter, Phase III pediatric trial in Mexico
por: Cruz-Valdez, Aurelio, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_ia01id73jet71pv5ftj0f1go0m